**Background**
The $\beta$-adrenergic receptor ($\beta$-AR) system plays a critical role in regulating cardiovascular function, respiratory activity, and metabolic processes by mediating the effects of catecholamines. Dysregulation of these receptors is often associated with various cardiovascular diseases, including hypertension and cardiac arrhythmias. Consequently, $\beta$-adrenergic receptor antagonists, commonly known as beta-blockers, have become essential pharmacological tools for managing these conditions and are widely used in biomedical research to study sympathetic nervous system activity. Understanding the binding characteristics and efficacy of these antagonists is vital for developing targeted therapies. In this context, we will introduce a potent $\beta$-AR antagonist – Oxprenolol.
**Definition**
Oxprenolol is an orally bioavailable $\beta$-adrenergic receptor antagonist with a $K_i$ value of 7.10 nM in radioligand binding assays using rat heart muscle.
**In Vitro and In Vivo Studies**
According to the Oxprenolol technical information, this compound is lipophilic and exhibits a permeability rate constant of $1.54 \pm 1.54 \times 10^{-3}$ cm/h across abdominal human skin. In terms of Oxprenolol biological activity, in vitro studies using Vero E6 cells demonstrated that the compound has a cytotoxicity value ($CC_{50}$) of $> 40$ $\mu$M. Furthermore, it showed antiviral efficacy against SARS-CoV-2 (strain BavPat1) in Vero E6 cells, with an $EC_{50}$ of 20.22 $\mu$M, as measured by the inhibition of viral RNA replication via RT-PCR after 2 days.
Regarding Oxprenolol in vivo application, research using male Wistar rats (230 to 300 g body weight) showed that the administration of Oxprenolol at a dosage of 200 mg/kg/day via oral route for 3 weeks produced effective beta-blockade. These findings highlight the compound’s potency and bioavailability in animal models. In conclusion, Oxprenolol is a lipophilic $\beta$-adrenoceptor antagonist that provides effective beta-blockade and exhibits potential antiviral properties.
Keywords
Oxprenolol, 6452-73-9, Ba 39089, Ba39089, Ba-39089, Adrenergic Receptor, Beta Receptor, heart, disease angina, hypertension, arrhythmia, high, blood, pressure, heartbeats, Inhibitor, inhibitor, inhibit
References
[1] T Nagatomo, et al. Binding Characteristics of 3H-dihydroalprenolol to Beta-Adrenoceptors of Rat Heart Treated With Neuraminidase. Jpn J Pharmacol. 1983 Aug;33(4):851-7.
[2] A S Manning, et al. Abrupt Withdrawal of Chronic Beta-Blockade: Adaptive Changes in Cyclic AMP and Contractility. J Mol Cell Cardiol. 1981 Nov;13(11):999-1009.
[3] Modamio P, et al. A comparative in vitro study of percutaneous penetration of β-blockers in human skin. International journal of pharmaceutics, 2000, 194(2): 249-259.